about
Molecular Imaging of Metabolic Reprograming in Mutant IDH CellsImaging Renal Urea Handling in Rats at Millimeter Resolution using Hyperpolarized Magnetic Resonance Relaxometry.Magnetic Resonance (MR) Metabolic Imaging in Glioma.Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylaseMetabolic reprogramming in mutant IDH1 glioma cells.Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 teslaMR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.Non-invasive in vivo assessment of IDH1 mutational status in glioma.Studies of Metabolism Using (13)C MRS of Hyperpolarized Probes.Lactate dehydrogenase A silencing in IDH mutant gliomas.IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells.Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites.Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in gliomaHyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model.Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine.CBIO-42DOWN REGULATION OF PYRUVATE DEHYDROGENASE ACTIVITY IS ESSENTIAL FOR CELL PROLIFERATION IN IDH1 MUTANT GLIOMA CELLS.METABOLIC IMAGING BIOMARKERS FOR MUTANT IDH1 GLIOMAS.In vivo metabolic imaging of Traumatic Brain Injury.Diffusion-weighted NMR spectroscopy allows probing of 13C labeling of glutamate inside distinct metabolic compartments in the brain.BI-07HYPERPOLARIZED [1-13C] GLUTAMATE: A METABOLIC IMAGING BIOMARKER OF IDH1 MUTATIONAL STATUS IN GLIOMA.TM-0713C MRS DETECTS METABOLIC FLUX ADAPTATION IN IDH MUTANT GLIOMA CELLS.Repeated Mild Head Injury Leads to Wide-Ranging Deficits in Higher-Order Cognitive Functions Associated with the Prefrontal CortexTraumatic Brain Injury in Aged Mice Induces Chronic Microglia Activation, Synapse Loss, and Complement-Dependent Memory DeficitsHDAC inhibition in glioblastoma monitored by hyperpolarized 13 C MRSIFirst hyperpolarized [2-13C]pyruvate MR studies of human brain metabolismLongitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imagingHyperpolarized 13 C magnetic resonance spectroscopy detects toxin-induced neuroinflammation in miceMETB-14. DOWN-REGULATION OF ACETATE METABOLISM TOWARDS FATTY ACIDS IN IDH1 MUTANT GLIOMATMOD-20. EARLY DETECTION OF HDAC INHIBITION IN GLIOBLASTOMA USING ADVANCED HYPERPOLARIZED C MRSIEXTH-71. HYPERPOLARIZED [1-C] PYRUVATE AS A BIOMARKER FOR TREATMENT MONITORING IN LYMPHOMA MURINE MODELS
P50
Q26750861-D5FB7F77-2B5B-4590-9590-DFF12883A46EQ27342014-47EDA65D-2C43-4C1C-9030-D56A84BF2BBDQ31015256-9B133CA0-BE16-4A11-839A-F71871DBA1D5Q35268977-F947C15B-43F8-4FFE-B407-46AA5E48EF5BQ35566048-9748B7B2-43D3-4212-87BB-E23F93DE19D1Q36127425-7F3A84F9-6B3D-4812-976D-D51A8B2B376CQ36918102-74FB9305-810C-4CA6-99FB-B2A643F3FA98Q37081252-FB0DD64E-721D-44F6-B674-93FC62B1E11AQ37537230-B0443260-4BB8-4CBB-8108-396783044890Q38584558-841C31B4-466C-4310-9641-1567811D69FDQ38720671-9CC3F632-8F7A-4965-B078-5645FE7CBFFFQ38867300-6F0424AC-033E-49F8-AEF6-85944D434852Q38947387-F27F74F2-1114-4678-BE2F-C0B870DEDD40Q38957381-7A70A1E4-7980-4B68-89A7-E1963F71CD0DQ38990221-00BB1407-A9F8-4BC3-8112-56512CB79D25Q41476817-B755AFBF-FEBD-4D31-A411-C2CDCDFDA102Q42368949-D281DAD4-ADCE-477F-90B3-8358CC4CED2BQ45831964-A5D0EECA-FE4E-41CB-B29C-680BCBBF204BQ45842249-47636C7E-F917-4993-8025-8F01BFED9D1AQ46241215-CBAEFFD9-9CEE-4A45-9A3A-53D2F2CA4829Q46455867-E1EDD315-F744-467C-8B65-D492C92DA6CBQ46947106-AC7C83EE-C001-4FDA-9343-92C62C76A48FQ55618430-342A6945-D324-4B51-AA87-7770990DAED8Q57464921-A20B4BD7-198D-4D53-BF9A-DDD45FFE9C5CQ60939575-678309C4-0C4A-4D42-BFB5-6C96DBC1461BQ90611895-DF0DDD3F-B75E-4EA2-8B1D-846E1174F047Q90924255-88598F5A-8D78-4F8B-8E58-289A172DD656Q91773475-1F08D75C-18E5-4C6D-A8FD-46B8CDD46CC4Q92774171-41B40E72-5BAE-456F-A731-924722696A45Q94404929-0EE7020C-9C5E-47A3-A5E4-4B59EF322FE5Q94405988-A926624F-B2E5-48E6-B0FA-8C07F811C7B9Q94408398-C9F8CE67-89FA-49AA-86BF-764AE3F072A7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Myriam Chaumeil
@en
Myriam Chaumeil
@nl
type
label
Myriam Chaumeil
@en
Myriam Chaumeil
@nl
prefLabel
Myriam Chaumeil
@en
Myriam Chaumeil
@nl
P31
P496
0000-0002-2110-4613